<DOC>
	<DOCNO>NCT02660112</DOCNO>
	<brief_summary>This 24-week study test safety effectiveness synthetically produce ( + ) Epicatechin treat patient Friedreich 's Ataxia , neurological disorder .</brief_summary>
	<brief_title>( + ) Epicatechin Treat Friedreich 's Ataxia</brief_title>
	<detailed_description />
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<criteria>Confirmed diagnosis Friedreich 's Ataxia ( FA ) Frataxin genetic test and/or Frataxin enzyme analysis Between age 10 50 year age , inclusive Body weight 25 kilogram high Minimum one affect organ ( cardiac neurological ) system , evidence clinical signs/symptoms Disease duration â‰¤7 year , base onset date FA symptom Has know contraindication gadolinium contrast severe allergy Glomerular Filtration Rate &lt; 30 ml/min/m^2 . Has know contraindication noncontrast Magnetic Resonance Imaging ( MRI ) evaluation pacemaker magnetically active metal fragment . Women childbearing age must : Have negative pregnancy human chorionic gonadotropin test prior receive study drug . Agree use contraception duration study drug dosing , plus 1 month completion study . Advanced cardiac failure , New York Heart Association ( NYHA ) Classification ScaleClass IV ( advanced stage heart failure ) Clinically significant comorbidities may also lead cardiomyopathy , example long stand hypertension , familial cardiomyopathy . Clinically significant comorbidities would , opinion investigator , compromise interpretation test result . Pregnant , breastfeed plan become pregnant study timeframe . Patients contraindication regadenoson , i. e. second thirddegree atrioventricular ( AV ) block sinus node dysfunction . Has receive investigational drug within thirty ( 30 ) day baseline visit . Thrombocytopenia ( &lt; 125 x 10^9/Liter ) prolong Prothrombin Time/Partial Thromboplastin Time ( PT/PTT ) baseline . Clinically significant hypotension ( systolic blood pressure &lt; 90 ) due heart failure condition .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>